Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Mosalli, Rafat ^a   AlFaleh, K ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN SYNTHASE INHIBITOR;

BIRTH; COMPARATIVE STUDY; DATA ANALYSIS; DATA EXTRACTION; HIGH RISK INFANT; HUMAN; LIGATION; LOW BIRTH WEIGHT; MORBIDITY; MORTALITY; PATENT DUCTUS ARTERIOSUS; PROPHYLAXIS; QUALITY CONTROL; REVIEW; SAFETY; SYSTEMATIC REVIEW;

EID: 37649030985     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006181     Document Type: Review

References (33)

1. Al-Faleh K, Smyth JA, Roberts RA, Solimano A, Asztalos EV, Schmidt B. Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely-low-birth-weight (ELBW) infants: results from the trial of indomethacin prophylaxis in preterms (TIPP). E-PAS (Pediatric Academic Societies) 2004:Abstract 2589.
2. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Seminars in Neonatology 2003;1:63-71.
3. Bayley N. Manual for the Bayley Scales of Infant Development. 2nd Edition. San Antonio, Tex.: Psychological Corporation, 1993.
4. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187:1-7.
5. Brook M, Heymann M. Patent ductus arteriosus. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP editor(s). Heart Disease in Infants, Children and Adolescents Including the Fetus and Young Adult.Williams & Wilkins, 1995:746-64.
6. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. The Journal of Pediatrics 1979;95:865-6.
7. Chen KB, Tu KT, Cheng HC, Wu YL, Chang JS. The anesthetic managementof a preterm infant weighing 500 gms undergoing ligation of patent ductus arteriosus. Acta Anaesthesiologica Sinica 1999;37:89-92.
8. Clyman R. Developmental physiology of the ductus arteriosus. In: Long W editor(s). Fetal and Neonatal Cardiology. Philadelphia: WB Saunders, 1990:64-75.
9. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. Journal of Pediatrics 1996;128:601-7.
10. Clyman RI, Waleh N, Black SM. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatric Research 1998;43:633-44.
11. Clyman R, Narayanan M. Patent ductus arteriosus: a physiologic basis for current treatment practices. Current Topics in Neonatology. Philadelphia: WB Saunders, 2000:71-91.
12. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. The Journal of Pediatrics 1979;2:467-73.
13. Duddell GG, Gersony M. Patent ductus arteriosus in neonates with severe respiratory disease. Journal of Pediatrics 1984;104:915-20.
14. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. In: The Cochrane Database of Systematic Reviews, 4, 2002.
15. Hammerman C. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clinics of Perinatology 1995;22:457-79.
16. Kitterman JA, Edmunds LH, Gregory GA, Heymann MA, Tooley H, Rudolph AM. Patent ductus arteriosus in premature infants: incidence and relation to pulmonary disease and management. New England Journal of Medicine 1972;287:473-7.
17. Kluckow M, Evans N. Ductal shunting, high pulmonary blood ow and pulmonary hemorrhage. Journal of Pediatrics 2000;137:68-72.
18. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. In: The Cochrane Database of Systematic Reviews, 3, 2003.
19. Martin CG, Snider AR, Katz SM, Peabody JL, Brady JP. Abnormal cerebral ow patterns in preterm infants with a large patent ductus arteriosus. Journal of Pediatrics 1982;101:587-93.
20. Mouzinho AI, Rosenfeld CR, Risser R. Symptomatic patent ductus arteriosus in very low birth weight infants. Early Human Development 1991;27:65-77.
21. Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Norton JB, Radinger RI. Indomethacin treatment in patent ductus arteriosus: a double blind study utilizing indomethacin plasma levels. Developmental Pharmacology and Therapeutics 1980;1:125-36.
22. Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003;112:33-9.
23. Palder SB, Schwartz M, Tyson K, Marr C. Management of patent ductus arteriosus: comparison of operative vs pharmacologic treatment. Journal of Pediatric Surgery 1987;22:1171-4.
24. Papile LA, Burstein J, Burstein R, Kofer H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics 1978;92:529-34.
25. Pokharel R, Hisano K, Yasufuku M, Ataka K, Okada M, Yoshimoto S. Ligation of medically refracted patent ductus arteriosus (PDA) in an extremely low body weight premature infant. Surgery Today 1998;28:1290-4.
26. Reller MD, Rice MJ, McDonald RW. Review of studies evaluating ductal patency in the premature infant. Journal of Pediatrics 1993;122:S59-62.
27. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. Journal of Pediatrics 1995;126:605-10.
28. Satur CR, Walker DR, Dickinson DF. Day case ligation of patent ductus arteriosus in preterm infants. A ten year review. Archives of Disease in Childhood 1991;66:477-80.
29. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants. New England Journal of Medicine 2001;344:1966-72.
30. Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and oxygen blood ow in preterm infants with respiratory distress syndrome treated with surfactant. Journal of Pediatrics 1994;125:270-277.
31. Trus T, Winthrop AL, Pipe S, Shah J, Langer JC, Lau GY. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. Journal of Pediatric Surgery 1993;28:1137-9.
32. Wagner HR, Ellison C, Zierler S, Lang P, Purohit DM, Behrendt D, et al. Surgical closure of patent ductus arteriosus in 268 preterm infants. Journal of Thoracic and Cardiovascular Surgery 1984;87:870-5.
33. Weir FJ, Ohlsson A, Myhr TL, Fong K, Rayan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood ow velocity. European Journal of Pediatrics 1999;158:484-7.